Central Trust Company’s GeneDx Holdings WGS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$507 Hold
7
– – ﹤0.01% 1524
2026
Q2
$481 Hold
7
– – ﹤0.01% 1532
2026
Q1
$450 Buy
+7
New +$638 ﹤0.01% 1502

Other funds holding WGS

Central Trust Company's WGS Position: Q3 2026 in Review

Central Trust Company held its GeneDx Holdings (WGS) position steady in Q3 2026 at 7 shares worth $507. The position accounts for ﹤0.01% of the portfolio, ranked #1524.

Central Trust Company first reported a position in WGS in Q1 2026 and has held it in 3 quarters since. 219 funds tracked by Wall St. Rank hold WGS as of Q3 2026.

  • Central Trust Company held 7 shares of GeneDx Holdings worth $507 as of Q3 2026.
  • Central Trust Company left its GeneDx Holdings share count unchanged in Q3 2026.
  • GeneDx Holdings made up ﹤0.01% of Central Trust Company's portfolio in Q3 2026, its #1524 holding.
  • Central Trust Company first reported a position in GeneDx Holdings in Q1 2026 and has held it in 3 quarters since.
  • 219 funds tracked by Wall St. Rank held GeneDx Holdings as of Q3 2026.

Based on Central Trust Company's 13F filing for Q3 2026, filed 5 Nov 2026.